Abeona Therapeutics Inc.

US$4.17As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ABEOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (30.67%)
Div yield —
ROE (43.13%)
Biotechnology
Beta (5Y) 1.48
PE TTM —
TSR TTM (13.31%)
Mkt cap US$238.5M
ROIC (31.15%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.82
15.61%
(39.70%)
Hold 6|12|1|6|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.06
15.26%
8.47%
11.66%
8.10%
Revenue$M
13.62
13.69
14.15
14.21
(2.60%)
(0.13%)
(0.79%)
1.21%
Peers (US$238.5M)
Cap (US$)
PE
241.3M
—
Capital
TTM
5Y
10Y
Leveragex
1.165
(0.210)
(0.150)
EBIT/Intx
2.668
1.541
1.367
Own earn%
(5.49)
102.23
98.74
Sh yield%
29.52
61.10
54.65
Owners
Insiders/Inst%
2.58
38.51
Short interest%
0.89
SBC / revenue%
4.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
17–21
$1 testx
0.9
Incr. ROIC%
18